In the first of a two-part series with TB and HIV experts at the Bill & Melinda Gates Foundation, Dr. Stefano Bertozzi, director of HIV and tuberculosis programs at the Foundation, gives his thoughts on what lies ahead this year in HIV and TB building on key developments from the past year and a half. In his role, Dr. Bertozzi oversees grants in HIV vaccine development, biomedical prevention research, diagnostics development and resistance monitoring, and strategies for introduction and scaling-up of interventions. He has held past leadership roles at UNAIDS, the World Health Organization, the World Bank, and the National Institute of Public Health (INSP) in Mexico.
Innovative approaches can help find vulnerable young women in need of HIV prevention services The following is a guest post by Michelle Li, MS, and Quinn […]
In the six weeks before South Africa responded its first diagnoses of COVID-19 with the start of physical distancing measures, more than 47,000 people on average […]
CDC urges physicians, parents to be on lookout for AFM, a polio-like illness seen predominately in children
With 2018 data showing highest incidence acute flaccid myelitis since monitoring began, officials say awareness, recognition of rare life threatening condition will be crucial to early […]
By Karen Carvajal, M.D. Over the course of human history we have come a long way in our fight against the threat of infectious diseases and, […]